Phase 1a is not "delayed" it is in process28 Jul 2022 11:20
Hello Mr Ponity,
Welcome to the BB.
I am responding to your posts but on a different thread because I personally prefer not to use the word "delay" in this context and I think such headings give a negative connotation.
I am not having a go but in many of the discussions we have had on this BB the word delay has been used as a tool to shift the narrative to a negative one, when in fact, IMO, we should regard all timelines as flexible and manage our expectations accordingly. As has been said, the Clinicians are managing this trial and it will take as long as it takes. It cannott be described as "early" nor can it be described as "delayed". It will get here when it gets here.
As for your idea that the release might be being managed, I agree that is quite possible. I have thought it over and (speaking as an obvious non-scientist and certainly only in my opinion) my view is that if this trial pans out as we believe/hope it will, then the news will be immense.
The news will go way beyond a mere RNS. There will have to be announcements, journal articles perhaps, peer to peer communication etc making clear just what an earth moving change has accured. Oncologists the world over will want to know about it and the RNS alone will not suffice. This will have to be prepared and managed.
Then there are, as you point out, the possible Big Pharma players in the data room. I suspect that the timing of any data release is more likely to be influenced by them than by the impatient demands of some PIs. The financial impact will be huge and will be stage-managed. They will not be rushed.
Then there is the mainstream media. If and when this becomes news, I would expect the reaction in the Press will be sensational, in every sense. So press releases etc will need to be managed and well-timed too.
Of course, I may be wrong . . . but I genuinely feel that if this goes as we hope, then "disruptive" will not siffice to describe what is happening to Oncology and the treatment of future cancer sufferers.
None of this is going to force Avactas hand. I agree with you, AS is a master strategist and he will manage the release of results to maximum benefit . . . his, Avacta`s, Oncology`s and ours. I am prepared to wait however long it takes for that.
Good luck (to all of us)